Moreover, CDK1 was recently identified as the target of a competing endogenous RNA (ceRNA) mechanism (lncRNA PVT1/miR-31) in the facilitation of bladder cancer progression [37]. The gene discussed is PVT1; the disease is urinary bladder cancer.